Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Recruiting · NCT05761093 · Observational (researchers observe without assigning treatment) · Lead sponsor: Chinese University of Hong Kong
View the official record on ClinicalTrials.gov →What this trial is about
The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- aged 18 years or older,
- diagnosis of metastatic prostate cancer within 5 years,
- able to read and write,
- accepting and signing the informed consent
Exclusion criteria
- if patients are unable to complete the survey by themselves due to physical or psychological reasons,
- deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons,
- deemed ineligible by treating physicians
Where it is running
1 location listed.
- Prince of Wales Hospital - Shatin, Hong Kong